key: cord-0749959-ukhly6bz authors: Noushad, Mohammed; Al-Saqqaf, Inas Shakeeb AbdulWareth title: COVID-19: Is herd immunity, the only option for fragile Yemen? date: 2021-03-15 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.03.030 sha: f41ae06e072d6a2200c5397ed9a94e8927fe3c33 doc_id: 749959 cord_uid: ukhly6bz The first case of COVID-19 in Yemen was confirmed on 10 April 2020. Having faced with a six-year long conflict that has destroyed half of its healthcare facilities and displaced millions, predictions of infections and mortality in Yemen suggested a looming healthcare catastrophe. Difficulty in implementing coordinated lockdowns and preventive measures due to the daily labor working nature of the majority of the population, provided the perfect breeding ground for the SARS-CoV-2 virus. However, official figures of infections and mortality are very low and there have not been confirmed reports of excess mortality. This could indicate that Yemen is silently marching towards forced herd immunity. Seroprevalence studies will provide useful insight into the COVID-19 transmission trajectory in Yemen, which can serve as a guide in planning vaccine distribution strategies and allocating the limited funds wisely. The emergence of the SARS-CoV-2 virus has renewed the debate on herd immunity. Although the concept seems plausible in an ideal setting, to get there, however, would possibly require the intentional sacrifice of a section of the herd, not only in terms of loss of life, but also in terms of long-term pain and suffering. For example, there have been suggestions that in the US alone, up to 2 million people would die before getting there (Aschwanden, 2020) . Although commentators in the Lancet have concluded that "any proposed approach to achieve herd immunity through natural infection is not only highly unethical, but also unachievable", it could be the only option for certain resource-poor and fragile nations (Jones and Helmreich, 2020) . In real life, attaining herd immunity to COVID-19 is not simple. Historically, no disease has been eradicated as a result of natural herd immunity (Aschwanden, 2020) . Aiming for herd immunity would require a steadfast disease surveillance mechanism to track and analyze the course of the disease transmission, and a robust healthcare system to absorb any sudden turn of events leading to an unexpected explosion in the number of infections. Proponents of herd immunity, like Sweden has witnessed deaths reaching up to 12826 per 1 million population, which is approx. 10 times its neighbors Norway (114) and Finland (134), forcing it to implement incremental interventions. In Dec 2020, the Swedish Corona Commission concluded that "the single most important factor behind the major outbreaks and the high number of deaths in [elderly] residential care is the overall spread of the virus in the society" Much of the argument on herd immunity has revolved around attaining it in stable countries. However, would the concept hold ground in fragile nations like Yemen, battered by six years of conflict, is devoid of a unified government, lacks a nation-wide robust and unified surveillance mechanism, and has a crippled healthcare system? Only 51% of the healthcare facilities in Yemen are fully functioning, and there is a severe shortage of healthcare Yemen has a female population of about 50 per cent and majority of them are already accustomed to wearing the face veil, which acts as a form of face mask. This could possibly prevent infections or lead to infections that are relatively mild or asymptomatic due to decreased viral inoculum, and also reduce transmissibility to others (Gandhi and Rutherford, 2020) . The presence of cross-reactive memory T cells, and trained immunity from exposure to other RNA viruses like dengue, chikungunya, Middle East respiratory syndrome-related Coronavirus (MERS-CoV), measles, etc. could be important protective factors. Since the SARS-CoV-2 does not stimulate a robust interferon, a trained cell would be more likely to raise a response against it compared to a non-trained cell (Chinnaswamy, 2020; Lipsitch et al., 2020) . Although cross immunity and trained immunity may not decrease the transmission rate, it could possibly be the reason to limit disease severity and mortality. Seroprevalence studies will give a better understanding on the COVID-19 transmission trajectory in Yemen. Seroprevalence studies on COVID-19 in other countries have always indicated much higher infections than reported (Byambasuren et al., 2020) . For example, a study in India indicated that the number of infections was 130 times higher than the reported number, during the study period (Murhekar et al., 2020) . Severe shortages in testing capacity, personal protective equipment and supplies highlighting major discrepancies in funding and logistics due to closure of air and seaports and as a result of the ongoing conflict, indicates expected future difficulties in attaining vaccine coverage. Herd immunity could be the only option for Yemen. Given the low mortality due to COVID-19 in cash strapped Yemen, a country specific strategy will be necessary to minimize the burden on the healthcare system and the population in general (Chakrabarti et al., 2020) . This is especially true since the recent high-le vel UN international pledging event for Yemen has been "disappointing". Lockdowns that lead to economic suffocation of the daily wageearning population seem unnecessary in the Yemeni context, a strategy that has especially proven to have drastic consequences on the migrant workers in India. On the other hand, priority should also be given to allocation of the limited funds for restructuring the healthcare system, timely payment of wages to doctors and other healthcare personnel, improving facilities for testing and management of only critical COVID-19 cases, and protecting the vulnerable. In view of this, the need of the hour is implementation of seroprevalence studies, even at a small scale, especially in areas suspected of high COVID-19 burden. Seroprevalence studies will provide more accurate information on the rate of virus transmission and the country specific behavior of the virus in Yemen, and also aid in pinpointing areas where future outbreaks can be expected. It will also serve as a guide in planning future health strategies, to optimize vaccine distribution and to prevent over-J o u r n a l P r e -p r o o f allocation of funds for COVID-19, keeping in mind other concurring disease outbreaks and a conflict-devastated healthcare system. No external funding was received. No ethical approval was required. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Effect of timing of and adherence to social distancing measures on COVID-19 burden in the United States Healthcare workers' knowledge, preparedness, counselling practices, and perceived barriers to confront COVID-19: A cross-sectional study from a war-torn country COVID-19, other illnesses kill hundreds in Yemen. Arab News Yemeni students return to school as virus cases slow The first 2 months of the SARS-CoV-2 epidemic in Yemen: analysis of the surveillance data The false promise of herd immunity for COVID-19 Yemen: how COVID-19 spread in a war zone Excess mortality during the COVID-19 pandemic in Aden governorate, Yemen: a geospatial and statistical analysis. medRxiv Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: systematic review Cholera epidemic in Yemen, 2016-18: an analysis of surveillance data Of Cross-immunity, Herd Immunity and Country-specific Plans: Experiences from COVID-19 in India CoV-2 infection in India bucks the trend: Trained innate immunity? COVID-19 and the Swedish enigma Fears of "highly catastrophic" COVID-19 spread in Yemen Facial masking for COVID-19 -Potential for variolation as we await a vaccine A history of herd immunity COVID-19 -a very visible pandemic Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events Cross-reactive memory T cells and herd immunity to SARS-CoV-2 Covid-19: Deaths in Yemen are five times global average as healthcare collapses Validation of the Wild-type Influenza A Human Challenge Model H1N1pdMIST: An A(H1N1) pdm09 Dose-Finding Investigational New Drug Study Inefciency of SIR models in forecasting COVID-19 epidemic: a case study of Isfahan Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey Tens of millions of Yemenis' devastated by unabated war and COVID-19. United Nations The COVID-19 pandemic: diverse contexts; different epidemics-how and why? Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries Covid: No-lockdown Sweden to shut secondary schools for a month to combat second wave The authors extend their appreciation to the Deanship of Post Graduate and ScientificResearch at Dar Al UIoom University for their support for this work